Specific Issues and a Model of Care
Accessed; 08.10.2019
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...of Congo, Eswatini, Guinea, Kenya, Malawi, Mozambique, Myanmar and Zimbabwe. With a focus on the financial resources available, this report highlights the current risks and gaps in HIV and TB service delivery in these countries.
Given the findings of gaps in diagnosis, prevention and care services and dwindling resources, MSF calls for a robust assessment of the needs and the resource capacity of each affected country, and calls on international donors to ensure that the financial burden is shared, rather than shifted onto those countries worst affected by the diseases.
more
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
People living with HIV who have a low CD4 count are at a much higher risk of falling ill from TB infection than HIV negative people.
It is important to offer both HIV testing to TB patients and TB diagnosis in HIV patients. Early detection and effective treatment are essential to preventing TB...-associated deaths.
WHO and UNAIDS have strongly advised countries to ensure that HIV programmes integrate regular TB screening, preventive therapy and early treatment.
more
Rediscovering Biology
Molecular to Global Perspectives
Accessed: 03.09.2019
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
#AIDS2016 | @AIDS_conference
Accessed: 26.09.2019
Tokar A, et al. Sex Transm Infect 2019;95:193–200. doi:10.1136/sextrans-2018-053684
A Cost-Efficiency Analysis for the Kyrgyz Republi
Accelerating HIV prevention to reduce new infections by 75%
Yu et al. BMC Public Health (2018) 18:825 https://doi.org/10.1186/s12889-018-5731-z
Research Article
htb supplement: 2018 Vol 19:(1)
New drugs in development
July 2018
www.i-Base.info
Módulo 1
Clínico
Julho de 2017
Módulo 1: Clínico. Este módulo é destinado a profissionais de saúde como médicos, enfermeiros e auxiliares e traz um resumo sobre como prover a PrEP de forma segura e efetiva, abordando vários aspectos: triagem de pessoas com risco substancial de contr...air o HIV;
ódulo 1: Clínico. Este módulo é destinado a profissionais de saúde como médicos, enfermeiros e auxiliares e traz um resumo sobre como prover a PrEP de forma segura e efetiva, abordando vários aspectos: triagem de pessoas com risco substancial de contrair o HIV; testagem de HIV antes de iniciar a PrEP e como acompanhar usuários de PrEP e oferecer aconselhamento sobre adesão.
more